Conférences  >  Médecine & Soins de Santé  >  Médecine translationnelle, essais cliniques

The European Association for Cancer Research (EACR)

This conference will explore the fundamental mechanisms controlling cancer cell plasticity at multiple biological levels including the epigenome, transcriptome, metabolome, and cellular microenvironment. Our panel of expert speakers will also discuss innovative approaches to target cell plasticity using novel pharmacological interventions that aim to prevent or reverse the adaptive mechanisms cancer cells use to circumvent conventional therapies.

Chris Iliffe (Conference Officer);     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer cell biology, cancer cell plasticity, cancer epigenetics, cellular microenvironment, tumour microenvironment, tumour heterogeneity, cancer transcriptomics, metabolic reprogramming in cancer, phenotypic changes in cancer, cancer progression, cancer therapy resistance, virtual academic conference

Cancérologie,    Biologie moléculaire

IIT (BHU), Varanasi

Drug Discovery and Translational Healthcare 2025 (DDTH 2025) will be held on December 2-3, 2025, at the School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, India, in collaboration with two prestigious societies, Bioinformatics and Drug Discovery Society (BDDS)" and "Biotechnology Society of India (BSI) ". This two-day event will feature keynote, plenary, and invited lectures by leading scientists and academics, alongside oral and poster presentations by students. The conference will focus on applied bioinformatics and various aspects of translational healthcare. DDTH 2025 aims to offer an exceptional platform for staying up-to-date with the latest research, fostering information exchange, and enabling networking opportunities among researchers. We warmly invite you to submit your posters and register for the conference.

Organizing Chairman/Secretaries;     Tél.: [0000000000];     Email.: ddthiitbhuvaranasi@gmail.com

Computer Aided Drug Design/Structure-Based Drug Designing, Biotechnology and Healthcare, Omics and Bioinformatics for healthcare, Protein targets and therapeutic proteins

European Association for the Study of the Liver (EASL)

The need to understand basic epidemiological concepts cannot be overstated for researchers wanting to make a career in any medical field, including hepatology. This course will give an overview of common and cutting-edge methodologies in clinical epidemiology that will be highly useful for clinicians wanting to develop their capacity to read, interpret, and understand limitations of clinical studies in medical journals. Instead of presenting a clinical case, the course will focus on practical skills needed to understand or design clinical studies and to be able to spot flaws and limitations in their own and other’s research work. In essence, this course will improve the knowledge of applied clinical study design and methodology for the next generation of clinicians and clinical researchers in hepatology.

Hépatologie,    Formation médicale continue (FMC)